Based on GEP, a 3-gene model (TNFRSF8, BATF3, and TMOD1) was developed to separate ALK– ALCL from PTCL-NOS, with 97% accuracy (61). This evidence concerns the gene TMOD1 and mature T-cell and NK-cell non-Hodgkin lymphoma.